Integra LifeSciences Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Integra LifeSciences (IART) Tops Q2 EPS by 2c; Offers FY22 Guidance
July 27, 2022 6:36 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.82, $0.02 better than the analyst estimate of $0.80. Revenue for the quarter came in at $398 million versus the consensus estimate of $395.65 million.
GUIDANCE:
Integra LifeSciences sees FY2022 EPS of $3.21-$3.29, versus the consensus of $3.31.... More
